These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3519860)

  • 1. The murine antibody response to lactate dehydrogenase-elevating virus.
    Coutelier JP; Van Roost E; Lambotte P; Van Snick J
    J Gen Virol; 1986 Jun; 67 ( Pt 6)():1099-108. PubMed ID: 3519860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralization and sensitization of lactate dehydrogenase-elevating virus with monoclonal antibodies.
    Coutelier JP; Van Snick J
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():2097-100. PubMed ID: 3404124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyclonal B cell activation of IgG2a and IgG2b production by infection of mice with lactate dehydrogenase-elevating virus is partly dependent on CD4+ lymphocytes.
    Li X; Hu B; Harty J; Even C; Plagemann PG
    Viral Immunol; 1990; 3(4):273-88. PubMed ID: 2076177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased efficacy of the immunoglobulin G2a subclass in antibody-mediated protection against lactate dehydrogenase-elevating virus-induced polioencephalomyelitis revealed with switch mutants.
    Markine-Goriaynoff D; Coutelier JP
    J Virol; 2002 Jan; 76(1):432-5. PubMed ID: 11739710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formalin inactivation of the lactate dehydrogenase-elevating virus reveals a major neutralizing epitope not recognized during natural infection.
    Harty JT; Plagemann PG
    J Virol; 1988 Sep; 62(9):3210-6. PubMed ID: 2457113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal infection of mice with lactate dehydrogenase-elevating virus results in suppression of humoral antiviral immune response but does not alter the course of viraemia or the polyclonal activation of B cells and immune complex formation.
    Rowland RR; Even C; Anderson GW; Chen Z; Hu B; Plagemann PG
    J Gen Virol; 1994 May; 75 ( Pt 5)():1071-81. PubMed ID: 8176369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of monoclonal antibodies to the lactate dehydrogenase-elevating virus.
    Harty JT; Chan SP; Plagemann PG
    Intervirology; 1987; 27(1):53-60. PubMed ID: 3610572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody response of mice to lactate dehydrogenase-elevating virus during infection and immunization with inactivated virus.
    Cafruny WA; Chan SP; Harty JT; Yousefi S; Kowalchyk K; McDonald D; Foreman B; Budweg G; Plagemann PG
    Virus Res; 1986 Sep; 5(4):357-75. PubMed ID: 3022497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication of lactate dehydrogenase-elevating virus in C58 mice and quantification of antiviral antibodies and of tissue virus levels as a function of development of paralytic disease.
    Cafruny WA; Strancke CR; Kowalchyk K; Plagemann PG
    J Gen Virol; 1986 Jan; 67 ( Pt 1)():27-37. PubMed ID: 3944584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complexity of the single linear neutralization epitope of the mouse arterivirus lactate dehydrogenase-elevating virus.
    Plagemann PG
    Virology; 2001 Nov; 290(1):11-20. PubMed ID: 11882995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune complexes that bind to ELISA plates not coated with antigen in mice infected with lactate dehydrogenase-elevating virus: relationship to IgG2a- and IgG2b-specific polyclonal activation of B cells.
    Hu B; Even C; Plagemann PG
    Viral Immunol; 1992; 5(1):27-38. PubMed ID: 1610489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the specificity of antibodies in mice infected with lactate dehydrogenase-elevating virus.
    Gómez KA; Coutelier JP; Retegui LA
    Scand J Immunol; 1997 Aug; 46(2):168-74. PubMed ID: 9583997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of virus-specific antiserum corresponding to sequences in the lactate dehydrogenase-elevating virus (LDV) ORF6 protein.
    Takahashi-Omoe H; Omoe K; Sakaguchi M; Kameoka Y; Matsushita S; Inada T
    Comp Immunol Microbiol Infect Dis; 2004 Jan; 27(1):47-55. PubMed ID: 14656541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with inactivated lactate dehydrogenase-elevating virus followed by virus infection favors the selection of hybridomas synthesizing antibodies cross-reacting with intermediate filaments and the LDV envelope protein VP3.
    Grossmann A; Weiland E
    Autoimmunity; 1991; 8(4):329-33. PubMed ID: 1932516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difference in neutralization between lactate dehydrogenase-elevating virus isolated from acutely and chronically infected mice.
    Monteyne P; Coutelier JP
    J Gen Virol; 1994 May; 75 ( Pt 5)():1173-6. PubMed ID: 8176379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactate dehydrogenase-elevating virus induces anti-Golgi apparatus antibodies.
    Weiland E; Weiland F; Grossmann A
    J Gen Virol; 1987 Jul; 68 ( Pt 7)():1983-91. PubMed ID: 3598563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmunity induced by lactate dehydrogenase-elevating virus: monoclonal autoantibodies against Golgi antigens and other subcellular elements.
    Grossmann A; Weiland F; Weiland E
    Autoimmunity; 1989; 2(3):201-11. PubMed ID: 2491605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neutralization epitope of lactate dehydrogenase-elevating virus is located on the short ectodomain of the primary envelope glycoprotein.
    Li K; Chen Z; Plagemann P
    Virology; 1998 Mar; 242(2):239-45. PubMed ID: 9514969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathogenicity and sensitivity to antibody neutralization of lactate dehydrogenase-elevating virus are determined by polylactosaminoglycan chains on the primary envelope glycoprotein.
    Chen Z; Li K; Plagemann PG
    Virology; 2000 Jan; 266(1):88-98. PubMed ID: 10612663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody classes and subclasses in circulating immune complexes isolated from mice infected with lactic dehydrogenase virus.
    McDonald TL; Donnelly T; Weber A; Quenette L
    Immunology; 1983 Mar; 48(3):511-7. PubMed ID: 6826202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.